This page contains a Flash digital edition of a book.
bianchi_Layout 1 22/12/2009 13:45 Page 32
Osteoporosis
increase reported with calcium and vitamin D alone.
20
Of course, even The treatment of  TOH is mainly based on bed rest and limited
when bisphosphonates are used, adequate calcium and vitamin D are physical activity, using walkers or crutches to avoid weight-bearing,
absolutely necessary. Unfortunately, the small number of cases and appropriate hip mobilisation to prevent muscular contractures and
different treatment approaches do not allow a clear evaluation of use of non-steroidal anti-inflammatory drugs and analgesics for
treatment efficacy, so a rational strategy is still impossible. pain. Different surgical approaches after delivery have been
described in patients with hip fracture.
30
In cases with bilateral hip
Transient Osteoporosis of the Hip pain, elective Caesarean section has been proposed.
37
Regarding the
This disorder has been given several different names: TOH, use of bone-specific drugs, a study on three women with TOH used
algodystrophy of the hip and  idiopathic osteoporosis in pregnancy. sodium fluoride and calcium: two women had some improvement
It is a focal, transient osteoporosis primarily affecting the hip. It and the third remained stable.
38
Bisphosphonates also seem to be
generally occurs in the third trimester of pregnancy, without previous effective.
39
In a case of severe, persistent hip pain without
trauma or evident diseases. It starts with pain and limited hip mobility improvement after delivery, alendronate treatment effectively
and is frequently complicated by a fracture, the highest risk being relieved pain and other symptoms.
40
towards the end of pregnancy.
29–31
In another study on 13 pregnant and lactating women with TOH, eight
Affected women have unilateral or bilateral hip pain and limping. patients were treated with salmon calcitonin (100IU every other day)
They can sustain femoral neck fractures. A recent report described plus calcium supplements. The other five women were treated with
the first case of non-traumatic, bilateral, acetabular and femoral neck rest and mild analgesics only. The eight calcitonin-treated women had
fractures in a 23-year-old breastfeeding woman six days after her a faster resolution of pain and limping and a greater increase in hip
first delivery. The condition was so severe that it required bilateral BMD with respect to the other five. This study is also important
total hip arthroplasty.
32
because it showed the recurrence of TOH in two of the eight women
who had a subsequent pregnancy.
41
Reduced BMD of the affected hip has been observed in some
studies. With magnetic resonance imaging (MRI), joint effusion in Osteoporosis Associated with Heparin
the affected hip and diffuse signal abnormalities on the marrow of The risk of thromboembolic complications is increased during
the femoral head have been shown.
33
Radionuclide bone imaging pregnancy and immediately after delivery due to hypercoagulability,
performed a few days after the onset of symptoms is the best stasis of the venous circulation and delivery-related trauma. Women
with a previous history of thrombosis have a 5–12% probability of
recurrence. For this reason, prophylactic antithrombotic therapy is
The main forms of pregnancy-related
normally prescribed for a relatively long time.
osteoporosis are post-pregnancy spinal
Heparin used to be the choice treatment, as it does not cross the
osteoporosis, transient osteoporosis of
placenta. However, the use of heparin in pregnancy can lead to
osteoporosis in up to 30% of cases and to vertebral fractures in 2%.
42,43
the hip and osteoporosis associated
According to one of these studies,
42
the proximal hip BMD was
with heparin.
decreased by 10% or more from the baseline value in four of 14
women examined immediately after delivery.
technique for the diagnosis of pregnancy TOH. In fact,  TOH is In one of the first reports of heparin-induced osteoporosis during
characterised by increased radionuclide uptake in the femoral pregnancy, a significant reduction of the bone cortex of the phalanges
head, whereas reduced uptake occurs in hip osteonecrosis. In was observed in women who received heparin for 25 weeks with
addition, the uptake is within the bone in TOH, while it is respect to those who received it for  only seven  weeks.
44
In a large
characteristically synovial in infection or inflammatory arthritis, so retrospective study on 184 women, 17% of those treated with heparin
that a differential diagnosis seems easy.
34
Laboratory tests are showed osteopenia at X-ray examination of the spine or hip
usually as expected in any pregnant woman, but in some cases a immediately after delivery. After six to 12 months, the majority of
slightly increased erythrocyte sedimentation rate and low 1,25(OH)
2
cases recovered.
45
D levels have been reported.
35
The aetiology of heparin-induced osteoporosis is not clear: decreased
Various aetiological factors have been proposed to explain this collagen synthesis, increased osteoclast activity, secondary hyper-
localised osteoporosis: femoral venous stasis caused by the pregnant parathyroidism due to chelation of calcium ions and  inhibition of
uterus, local ischaemia, viral infection, marrow hypertrophy and foetal calcification due to the high affinity of heparin for calcium have all
pressure on the obturator nerve. Regarding the possible metabolic been proposed. In rats, only increased osteoclast activity and bone
alterations involved in TOH, negative calcium balance, increased resorption have been demonstrated.
46
demand for protein and minerals and increased activity of the adrenal
cortex have been considered.
29,36
Although there is no evidence of dose dependence, the prevention of
heparin-associated osteoporosis is based on the use of the lowest
An improvement in pain occurs rapidly after the end of pregnancy. possible doses of heparin, plus calcium supplements (1,000mg/day)
Both symptoms and radiological alterations usually disappear and vitamin D; however, the effectiveness of this approach is still
within two to nine months of delivery. In some cases, persistent hip unproven.
47
In some cases,  bisphosphonates have been given after
pain has been reported for six months or longer. delivery, but their effect could not be clearly evaluated.
32 EUROPEAN MUSCULOSKELETAL REVIEW
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116
Produced with Yudu - www.yudu.com